A CDMO enables pharmaceutical and biotechnology companies to scale efficiently by offering end-to-end development and manufacturing solutions. Through GMP compliance, advanced analytics, and regulatory expertise, CDMOs reduce development risks, improve operational efficiency, and support successful commercialization of innovative therapeutics. https://globhy.com/article/the-role-of-a-cdmo-in-gmp-compliant-cell-and-gene-therapy-production